Preview

merck a company analysis

Best Essays
Open Document
Open Document
3426 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
merck a company analysis
A Discussion on the Company’s Decision Making Process, Group Behavior and Organizational Structure

Abstract
Merck is a pharmaceutical and medical researching company that is dealing with managerial challenges in their daily business operations. Their background and their issues regarding the matter will then help one understand how the actual picture of the real accounts of the managerial decision processes that happen to actual multinational company operations. Having been able to outline the main problem of the company with regards to supply and distribution as well as chain management concerns will help comprehend the idealistic view of the company management. The following paragraphs shall discuss key factors of the background and history of Merck, which will set a foundation on the discussion of the issues and the solutions to the problem that would be tackled in this paper later on.

Introduction
Multinational companies have the capability of extending their services as well as their product distribution to any part of the world regardless of the industry that they are involved with. Additionally, Multinational companies enjoy the privilege of having a wide range of market share in the global trade. As for Merck, the existence of such a company in the world exchange of products and finance has had a great effect on the part for their gross and profit share in the business industry (Discover Merck , 2012). As a pharmaceutical company, Merck has amassed as one of the top suppliers of medicine to many parts of the world amongst both the rich and poverty-stricken countries.
However, although most multinational companies enjoy the benefits of being infamous on worldwide scales, there is still numerous times when such business organizations encounter several issues relating to business operational activities. The constant attendance of the company facilitators is often focused on the way the entire business system



References: Discover Merck . (n.d.). Merck. Retrieved July 2, 2012, from http /www .merck .de /servlet /PB /menu /1014820 /index .html MERCK CO , INC . BY-LAWS . (n.d.). Merck. Retrieved July 8, 2012, from http /www .merck .com /about /corporategovernance /docs /by_laws .pdf Merck History . (n.d.). Merck. Retrieved July 8, 2012, from http /pb .merck .de /servlet /PB /menu /1012970 POLICIES OF THE BOARD . (n.d.). Merck. Retrieved July 1, 2012, from http /www .merck .com /about /corporategovernance /docs /policy_board .pdf RESTATED CERTIFICATE OF INCORPORATION of MERCK CO INC . . (n.d.). Merck. Retrieved July 2, 2012, from http /www .merck .com /about /corporategovernance /docs /incorp_cert .pdf Robbins, S. P., & Judge, T. (2011). Organizational behavior (14th ed.). Upper Saddle River, N.J.: Prentice Hall. Hawthorne, F. (2005). The Merck druggernaut: the inside story of a pharmaceutical giant. Hoboken, N.J.: J. Wiley & Sons. Vagelos, P. R., & Galambos, L. (2004). Medicine, science and Merck. Cambridge, UK: Cambridge University Press.

You May Also Find These Documents Helpful

  • Better Essays

    Chem Lab

    • 858 Words
    • 4 Pages

    (2) The Merck Index: An Encyclopedia of Chemicals and Drugs, 12th edition. Siegmund, O.H.; Merck and Co: NJ,137,220.…

    • 858 Words
    • 4 Pages
    Better Essays
  • Good Essays

    2) O’neil, Maryadele, J’et al (2006,2012). The Merck Index- An Encyclopedia of chemicals, drugs and Biological. [14th edition-version 14.9 ]…

    • 403 Words
    • 2 Pages
    Good Essays
  • Good Essays

    References: Washington, H. A. (2011). Flacking for Big Pharma: Drugmakers Don 't Just Compromise Doctors; They Also Undermine the Top Medical Journals and Skew the Findings of Medical Research. (cover story). American Scholar, 80(3), 22. Retrieved from EBSCOhost.…

    • 738 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Merck Executive Summary

    • 496 Words
    • 2 Pages

    Merck & Co., Inc., a leading pharmaceutical company, faces the threat of the patents of its most popular drugs expiring in 2002. The only way to counter the loss of sales from these drugs going off patent is to develop new drugs in order to refresh the company’s portfolio. LAB Pharmaceuticals, a small pharmaceutical company who specializes in the treatment of neurological disorders, has approached Merck with the opportunity to license Davanrik, a new drug with the potential to treat both depression and obesity. The drug is currently in pre-clinical development and would still need to pass a seven year and three phase testing process approved by the FDA. Under the licensing agreement, Merck would compensate LAB with an initial fee, milestone payments as the drug progresses through each phase, and royalty on sales. Merck must make a decision on whether or not to license the drug. If Merck does decide to license the drug, it must also decide how much the drug is worth.…

    • 496 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Questions 6

    • 535 Words
    • 2 Pages

    2. What are the regulatory and legal issues related to drug and pharmaceutical development and sale?…

    • 535 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Merck’s open letters employ Aristotle’s idea of rhetoric by building appeal with the reader based on three foundations of ethos: wisdom, virtue and goodwill. This strategy is used in attempt to establish credibility and refute The Lancet claim that pharmaceutical giant “acted out of ruthless, shortsighted, and irresponsible self-interest” in Vioxx case. At first, the both documents try to establish Merck’s good judgment and knowledge by insisting the company conforms to ”scientific discipline and transparency”, performs ”rigorous scientific investigation” and brings “new medicines to patients who need them”. In addition, the “Open Letter” argues that as soon as data confirming the increased risks of Vioxx became available, the pharmaceutical giant “acted promptly and made the decision to voluntary withdraw” the drug. The letters further develop ethos with the audience by demonstrating Merck’s history of doing the right thing: “For more than 100 years,” the company “has produced life-saving benefits for countless…

    • 866 Words
    • 4 Pages
    Good Essays
  • Good Essays

    United Health Care

    • 800 Words
    • 4 Pages

    United HealthCare Services. (2011, January). United HealthCare Products & Services. Retrieved January 30, 2011, from http://www.uhc.com/about_us.htm…

    • 800 Words
    • 4 Pages
    Good Essays
  • Better Essays

    Health Insurance

    • 1350 Words
    • 6 Pages

    > History of Aetna Inc. – FundingUniverse. (n.d.). Find Funding with Banks, Investors, and Other Funding Sources | FundingUniverse. Retrieved May 11, 2013, from http://www.fundinguniverse.com/company-histories/aetna-inc-history/…

    • 1350 Words
    • 6 Pages
    Better Essays
  • Better Essays

    Essay or Mrsa

    • 1920 Words
    • 8 Pages

    3. Beers, M.H. & Berkow, R. (Eds.). (2005). The Merck Manual of Diagnosis and Therapy (17thed.).Whitehouse…

    • 1920 Words
    • 8 Pages
    Better Essays
  • Better Essays

    Managing Heart Failure

    • 1052 Words
    • 5 Pages

    References: Beers, Mark. ed., et al. Merck manual of Diagnosis and Therapy. New Jersey: Merck…

    • 1052 Words
    • 5 Pages
    Better Essays
  • Good Essays

    References: Axcan Pharma. (2010). Product update: Questions and answers. Retrieved August 21, 2010 from http://www.axcan.com/patient_product_qa.php?lang=1.…

    • 1613 Words
    • 7 Pages
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project.…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Good Essays

    amplified the risk of Merck coming up empty handed. Merck has a long history of being pioneers in the development of major antibiotic compounds, beginning with penicillin and streptomycin in the the1940s (Donaldson page 254). While scientists were encouraging the…

    • 790 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Addiction

    • 1324 Words
    • 6 Pages

    Cited: 1) Beers, Mark H.. The Merck manual of diagnosis and therapy. 18th ed. Whitehouse Station, N.J.: Merck Research Laboratories, 2006. Print.…

    • 1324 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Learningbydoing

    • 654 Words
    • 3 Pages

    Tahun 1980-an. Merck sukses dengan menjadi penggerak penilitan dan menjaga proses pembuatan produk-produk baru dan inovatif.…

    • 654 Words
    • 3 Pages
    Powerful Essays

Related Topics